Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC
Yahoo/Globe NewsWire
Sunday, September 7, 2014 - 10:41am
tags:
Novavax, RSV F vaccine
Study Shows Immigrants Hold Key Jobs in U.S. Pharma Sector
India West, India
Saturday, September 6, 2014 - 9:43am
tags:
FDA approves Keryx's kidney drug with warnings, shares fall
Yahoo/Reuters
Saturday, September 6, 2014 - 9:25am
tags:
Keryx, ferric citrate, chronic kidney disease
Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint
Yahoo/Zacks
Saturday, September 6, 2014 - 9:20am
tags:
Mallinckrodt, pain management, MNK-155
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Saturday, September 6, 2014 - 9:18am
tags:
Halozyme, PEGPH20, metastatic pancreatic cancer, pancreatic cancer
Why Gilead Is Falling On Drugs For Developing Nations
Investor's.com
Saturday, September 6, 2014 - 9:17am
tags:
Gilead Sciences
Merck's Anti-PD-1 Drug Keytruda First to be Launched in US
Yahoo/Zacks
Saturday, September 6, 2014 - 9:11am
tags:
Keytruda, Merck, melanoma
J&J Ordered to Pay $3.27 Million Over Mesh Implant
Bloomberg
Friday, September 5, 2014 - 4:06pm
tags:
pelvic mesh, JNJ, devices, Ethicon
Bristol-Myers Sues Merck Over Cancer Immunotherapy Patent
Bloomberg
Friday, September 5, 2014 - 4:02pm
tags:
Bristol-Myers Squibb, Merck, Keytruda
Huntington’s Disease Orphan Drug Designation Could Rescue Prana Read more: Huntington's Disease Orphan Drug Designation Could
24/7 Wall St
Friday, September 5, 2014 - 3:59pm
tags:
Huntington's disease, orphan drugs, Prana Biotechnology
Keryx Biopharma gets U.S. approval for kidney drug
Yahoo/Reuters
Friday, September 5, 2014 - 11:58am
tags:
FDA, Keryx, Zerenex, chronic kidney disease
Asthma: It’s a mAb, mAb, mAb, mAb world says analyst
Bio-Pharma Reporter
Friday, September 5, 2014 - 11:20am
tags:
asthma, monoclonal antibodies, Sanofi, Regeneron, Roche, GSK, AstraZeneca
Lilly Backs Lawsuit Against CMS Over its Alzheimer’s Diagnostic Drug
WSJ Pharmalot
Friday, September 5, 2014 - 11:10am
tags:
Eli Lilly, Alzheimer's disease, Amyvid, CMS, Medicare, Medicaid
FDA Draft Guidance Could Spur Innovation in Diabetes, Cardio Spaces
Medical Device and Diagnostics Industry
Friday, September 5, 2014 - 10:32am
tags:
FDA, innovation, diabetes, cardiology, devices
Drug black box warnings up post-Vioxx withdrawal
Oncology Practice
Friday, September 5, 2014 - 10:29am
tags:
black box, warnings
In FDA Effort to Strengthen Regulation of Compounded Drugs, Protections and Profits Intersect
RAPS.org
Friday, September 5, 2014 - 10:27am
tags:
FDA, compounding pharmacies
Recro tanks after hitting the brakes on its lead pain drug
Fierce Biotech
Friday, September 5, 2014 - 10:22am
tags:
Recro Pharma, Dex-IN, painkillers
OncoMed gets back on track as FDA clears another clinical hold
Fierce Biotech
Friday, September 5, 2014 - 10:21am
tags:
OncoMed, FDA, FZD8-Fc, ipafricept
A New Class of Cardiovascular Drug
The Chairman's Blog
Friday, September 5, 2014 - 10:13am
tags:
Capstone Therapeutics, AEM-28, Homozygous Familial Hypercholesterolemia
Cancer Drug Approval Is A Triumph For Merck. What's Next?
Forbes
Friday, September 5, 2014 - 10:04am
tags:
Merck, melanoma, Keytruda, Bristol-Myers Squibb, Opdivo

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.